These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25502729)

  • 41. Ductal Carcinoma In Situ - Quo Vadis?
    Peltecu G
    Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence.
    Jeschke U; Mylonas I; Kunert-Keil C; Dazert E; Shabani N; Werling M; Kuhn C; Janni W; Gerber B; Friese K
    Oncol Rep; 2005 Mar; 13(3):413-9. PubMed ID: 15706409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.
    Paudel N; Bethke KP; Wang LC; Strauss JB; Hayes JP; Donnelly ED
    Surg Oncol; 2018 Mar; 27(1):95-99. PubMed ID: 29549911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ: Evidence supporting the use of diverse pathways panels.
    Evans MF; Vacek PM; Sprague BL; Stein GS; Stein JL; Weaver DL
    J Cell Biochem; 2020 Feb; 121(2):1736-1746. PubMed ID: 31595577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is there a low-grade precursor pathway in breast cancer?
    King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
    Pilewskie M; Stempel M; Rosenfeld H; Eaton A; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3487-3493. PubMed ID: 27172775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Local recurrence outcomes after breast conserving surgery and adjuvant radiotherapy in ductal carcinoma in situ of the breast and a comparison with ECOG E5194 study.
    Ozkaya Akagunduz O; Ergen A; Erpolat P; Gultekin M; Akkus Yildirim B; Parvizi M; Ikiz D; Colpan Oksuz D; Onal C; Yildiz F; Ozsaran Z
    Breast; 2018 Dec; 42():10-14. PubMed ID: 30121548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radial scars diagnosed on breast core biopsy: Frequency of atypia and carcinoma on excision and implications for management.
    Donaldson AR; Sieck L; Booth CN; Calhoun BC
    Breast; 2016 Dec; 30():201-207. PubMed ID: 27371970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
    Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
    BMC Cancer; 2020 Jun; 20(1):513. PubMed ID: 32493410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
    Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
    J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
    Kerlikowske K; Molinaro AM; Gauthier ML; Berman HK; Waldman F; Bennington J; Sanchez H; Jimenez C; Stewart K; Chew K; Ljung BM; Tlsty TD
    J Natl Cancer Inst; 2010 May; 102(9):627-37. PubMed ID: 20427430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical treatment of ductal carcinoma in situ of the breast. 10- to 20-year follow-up.
    Simpson T; Thirlby RC; Dail DH
    Arch Surg; 1992 Apr; 127(4):468-72. PubMed ID: 1313671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
    Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA
    Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DCIS treated with excision alone using the National Comprehensive Cancer Network (NCCN) guidelines.
    Wehner P; Lagios MD; Silverstein MJ
    Ann Surg Oncol; 2013 Oct; 20(10):3175-9. PubMed ID: 23975306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy.
    White J; Levine A; Gustafson G; Wimbish K; Ingold J; Pettinga J; Matter R; Martinez A; Vicini F
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):791-7. PubMed ID: 7860390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
    Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.
    Cutuli B; De Lafontan B; Kirova Y; Auvray H; Tallet A; Avigdor S; Brunaud C; Delva C
    Radiat Oncol; 2015 May; 10():110. PubMed ID: 25944033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Age on Risk of Recurrence of Ductal Carcinoma In Situ: Outcomes of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.
    Cronin PA; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2016 Sep; 23(9):2816-24. PubMed ID: 27198513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics.
    Shatat L; Gloyeske N; Madan R; O'Neil M; Tawfik O; Fan F
    Hum Pathol; 2013 Dec; 44(12):2684-9. PubMed ID: 24071019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.